As per the National Diabetes Statistics Report, 2020, around 34.2 million people aged 18 years and above in the U.S. have diabetes. One-third of diabetics have kidney-related comorbidities due to high blood sugar and blood pressure. The rising incidence of kidney diseases is anticipated to increase demand for urinalysis products, boosting the market growth. Upgrading laboratory infrastructure in developing markets significantly depends on the investments made in healthcare and life sciences research in these nations.
According to Data Bridge Market Research the Global Urinalysis Market is expected to grow at a CAGR of 6% during the forecast period of 2022 to 2029, at a USD 3.18 billion in 2021 and is further estimated to reach USD 5.07 billion by 2029.
“Increasing Age-Related Diseases Surge the Market Growth”
The elderly population in both developed and developing countries will benefit the urinalysis market. The incidence of age-related illnesses such as liver, diabetes, and kidney disease is anticipated to rise dramatically as the aged population grows rapidly. The diagnosis and treatment of such conditions has resulted in increased prescriptions for tests such as albumin, glucose, creatinine, ketones, and bilirubin, among others. This market is anticipated to grow as urinalysis is helping in performing these tests. Thus, this factor will boost the growth of the market.
What restraints the growth of Global Urinalysis Market?
“Inaccuracy of Urinalysis Tests”
The urinalysis tests gives not so accurate results which impedes the market growth. Many of the dipstick results aren't completely correct, and many a times, gives you false positive results. The test depends on correct collection of sample by the patient, and if this is not done accurately the results may be wrong. The abnormalities that are witnessed with urinalysis can be found in normal people. These all are the major factors which impede the growth of the market.
Segmentation: Global Urinalysis Market
The global urinalysis market is segmented on the basis of testing type, product, modality, application, end user and distribution channel.
- On the basis of testing type, the urinalysis market is segmented into urine biochemistry testing and urine sediment testing.
- On the basis of product, the urinalysis market is segmented into instruments and consumables.
- On the basis of modality, the urinalysis market is segmented into portable, standalone, table top, bench top and others.
- On the basis of application, the urinalysis market is segmented into urinary tract infections, kidney diseases, diabetes, liver diseases, pregnancy and fertility and others.
- On the basis of end user, the urinalysis market is segmented into hospital, laboratory, homecare setting and others.
- On the basis of distribution channel, the urinalysis market is segmented into direct tenders and retail sales.
Regional Insights: North America is expected to dominate the Global Urinalysis Market
North America dominates the market due to the surge in the adoption of urinalysis for treatment of the liver disease and urinary tract infections. Additionally, increasing number of urinalysis patients will further enhance the growth of the urinalysis market in the region during the forecast period.
Asia-Pacific is expected to grow in the forecast period of 2022-2029 due to the rise in the initiatives taken by the government for the awareness related to the significance of diagnosis. Also, the rapid increase in the prevalence and occurrence of kidney cancer also boosts the market growth.
To know more about the study visit, https://www.databridgemarketresearch.com/pt/reports/global-urinalysis-market
Recent Developments in Global Urinalysis Market
- In 2020, Sysmex America, Inc. got authorized rights in North America to distribute and service Siemens Healthineers' CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.
- In 2021, OpGen, Inc. which is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help prevent infectious diseases, started a clinical trial for its Unyvero Urinary Tract Infection (UTI) Panel, which allows the testing of a huge range of pathogens, and antimicrobial resistance markers directly from native urine specimens.
The Prominent Key Players Operating in the Global Urinalysis Market Include:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Cardinal Health (U.S.)
- Abbott (U.S.)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Quidel Corporation (U.S.)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- EKF Diagnostics (U.K.)
- Thermo Fisher Scientific Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- ACON Laboratories, Inc. (U.S.)
- 77 Elektronika Kft. (Hungary)
- URIT MEDICAL ELECTRONIC GROUP CO., LTD. (China)
- Dirui Industrial Co., Ltd. (China)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- BIOBASE Group (China)
- ERBA Mannheim (U.K.)
- Alphatec Scientific E.I.R.L (Peru)
- Teco Diagnostics (U.S.)
- Analyticon Biotechnologies GmbH (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of global urinalysis market companies contact, https://www.databridgemarketresearch.com/pt/contact
Research Methodology: Global Urinalysis Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
